BioPharm
International's Structure, Comparability, and Biosimilars: Advances in Protein Characterization will discuss accepted and emerging methods for mapping, sequencing, secondary and tertiary structure, and post-translational modifications (e.g., glycosylation and pegylation), and potency/activity assays, including the strengths and weaknesses of the methods and their use in regulatory filings.
>>> The ad close for this supplement issue is
July 10 <<<
>>> The material due date is July 14
<<<
|
STRUCTURE, COMPARABILITY, AND BIOSIMILARS: ADVANCES IN PROTEIN CHARACTERIZATION EDITORIAL HIGHLIGHTS |
-
Overview: Current and Future Methods for Protein Characterization
-
Assessing the Comparability of Glycosylation During Scale-Up
-
High-Throughput Multi-Product Liquid Chromatography for the Characterization of Monoclonal Antibodies
-
Critical Biophysical Characterization for Establishing the Comparability of Biotherapeutic Compounds: a Comparative Study
-
NMR Spectroscopy Can Obtain Information on the Higher Order Structure of Biopharmaceutical Products
-
Rapid Assessment of Molecular Similarity Between a Candidate Biosimilar and an Innovator Monoclonal Antibody Using Complementary LC-MS Methods
-
Label-Free Protein Characterization and Quantitation
-
Capturing Shape Shifting in Proteins with Hydrogen Deuterium Exchange and LCMS
Contact Your Representative
Pat Venezia Jr.
732-346-3011
pvenezia@advanstar.com
James Gray
44(0)1244 393101
jgray@advanstar.com
|
